References
- 1Fittschen, A, Wendlik, I, Oeztuerk, S, et al. Prevalence of sporadic renal angiomyolipoma: A retrospective analysis of 61,389 in- and out-patients. Abdom Imaging. 2014; 39(5): 1009–1013. DOI: 10.1007/s00261-014-0129-6
- 2Flum, AS, Hamoui, N, Said, MA, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2017; 195(4): 834–846. DOI: 10.1016/j.juro.2015.07.126
- 3Jinzaki, M, Silverman, SG, Akita, H, Nagashima, Y, Mikami, S and Oya, M. Renal angiomyolipoma: A radiological classification and update on recent developments in diagnosis and management. Abdom Imaging. 2014; 39(3): 588–604. DOI: 10.1007/s00261-014-0083-3
- 4Jinzaki, M, Silverman, SG, Akita, H, Mikami, S and Oya, M. Diagnosis of renal angiomyolipomas: Classic, Fat-Poor, and Epithelioid types. Semin Ultrasound CT MR. 2017; 38(1): 37–46. DOI: 10.1053/j.sult.2016.11.001
- 5Lane, BR, Aydin, H, Danforth, TL, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: Classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008; 180(3): 836–843. DOI: 10.1016/j.juro.2008.05.041
- 6Johnson, SR, Taveira-DaSilva, AM and Moss, J. Lymphangioleiomyomatosis. Clin Chest Med. 2016; 37(3): 389–403. DOI: 10.1016/j.ccm.2016.04.002
- 7von Ranke, FM, Faria, IM, Zanetti, G, Hochhegger, B, Souza, AS,
Jr. and Marchiori, E. Imaging of tuberous sclerosis complex: A pictorial review. Radiol Bras. 2017; 50(1): 48–54. DOI: 10.1590/0100-3984.2016.0020 - 8Pirson, Y. Tuberous sclerosis complex-associated kidney angiomyolipoma: From contemplation to action. Nephrol Dial Transplant. 2013; 28(7): 1680–1685. DOI: 10.1093/ndt/gft009
- 9Song, S, Park, BK and Park, JJ. New radiologic classification of renal angiomyolipomas. Eur J Radiol. 2016; 85(10): 1835–1842. DOI: 10.1016/j.ejrad.2016.08.012
- 10Park, BK. Renal Angiomyolipoma: Radiologic Classification and Imaging Features According to the Amount of Fat. AJR Am J Roentgenol. 2017; 209(4): 826–835. DOI: 10.2214/AJR.17.17973
- 11Halpenny, D, Snow, A, McNeill, G and Torreggiani, WC. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol. 2010; 65(2): 99–108. DOI: 10.1016/j.crad.2009.09.014
- 12Logue, LG, Acker, RE and Sienko, AE. Best cases from the AFIP: Angiomyolipomas in tuberous sclerosis. Radiographics. 2003; 23(1): 241–246. DOI: 10.1148/rg.231025109
- 13Merran, S, Vieillefond, A, Peyromaure, M and Dupuy, C. Renal angiomyolipoma with calcification: CT-pathology correlation. Br J Radiol. 2004; 77(921): 782–783. DOI: 10.1259/bjr/33776173
- 14Schuster, TG, Ferguson, MR, Baker, DE, Schaldenbrand, JD and Solomon, MH. Papillary renal cell carcinoma containing fat without calcification mimicking angiomyolipoma on CT. AJR Am J Roentgenol. 2004; 183(5): 1402–1404. DOI: 10.2214/ajr.183.5.1831402
- 15Li, HM, Yeh, LR and Lu, K. Renal angiomyolipoma with coexistent hemorrhagic aneurysm formation and fatty thrombus in inferior vena cava: a rare presentation. Abdom Imaging. 2013; 38(1): 180–183. DOI: 10.1007/s00261-012-9886-2
- 16Israel, GM, Hindman, N, Hecht, E and Krinsky, G. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol. 2005; 184(6): 1868–1872. DOI: 10.2214/ajr.184.6.01841868
- 17Scialpi, M, Di Maggio, A, Midiri, M, Loperfido, A, Angelelli, G and Rotondo, A. Small renal masses: Assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. AJR Am J Roentgenol. 2000; 175(3): 751–757. DOI: 10.2214/ajr.175.3.1750751
- 18Sahni, VA and Silverman, ST. Biopsy of renal masses: When and why. Cancer Imaging. 2009; 9(1): 44–55. DOI: 10.1102/1470-7330.2009.0005
- 19Kiefer, RM and Stavropoulos, SW. The Role of Interventional Radiology Techniques in the Management of Renal Angiomyolipomas. Curr Urol Rep. 2017; 18(5): 36. DOI: 10.1007/s11934-017-0687-6
- 20Potretzke, AM, Potretzke, TA, Bauman, TM, et al. Computed Tomography and Magnetic Resonance Findings of Fat-Poor Angiomyolipomas. J Endourol. 2017; 31(2): 119–128. DOI: 10.1089/end.2016.0219
- 21Jeon, HG, Lee, SR, Kim, KH, et al. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: Prevalence and predictors in Korean patients. Urology. 2017; 76(3): 574–579. DOI: 10.1016/j.urology.2009.11.082
- 22Yang, CW, Shen, SH, Chang, YH, et al. Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? AJR Am J Roentgenol. 2013; 201(5): 1017–1028. DOI: 10.2214/AJR.12.10204
- 23Krishna, S, Murray, CA, McInnes, MD, et al. CT imaging of solid renal masses: pitfalls and solutions. Clin Radiol. 2017; 72(9): 708–721. DOI: 10.1016/j.crad.2017.05.003
- 24Kang, SK, Huang, WC, Pandharipande, PV and Chandarana, H. Solid renal masses: What the numbers tell us. AJR Am J Roentgenol. 2017; 202(6): 1196–1206. DOI: 10.2214/AJR.14.12502
- 25Kuusk, T, Biancari, F, Lane, B, et al. Treatment of renal angiomyolipoma: Pooled analysis of individual patient data. BMC Urol. 2015; 15: 123. DOI: 10.1186/s12894-015-0118-2
- 26Bhatt, JR, Richard, PO, Kim, NS, et al. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4 cm Can Be Offered Active Surveillance as an Initial Management Strategy. Eur Urol. 2016; 70(1): 85–90. DOI: 10.1016/j.eururo.2016.01.048
- 27Murray, TE, Doyle, F and Lee, M. Transarterial Embolization of Angiomyolipoma: A Systematic Review. J Urol. 2017; 194(3): 635–639. DOI: 10.1016/j.juro.2015.04.081
- 28Krueger, DA and Northrup, H. Tuberous sclerosis complex surveillance and management: Recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013; 49(4): 255–265. DOI: 10.1016/j.pediatrneurol.2013.08.002
- 29Maclean, DFW, Sultana, R, Radwan, R, McKnight, L and Khastgir, J. Is the follow-up of small renal angiomyolipomas a necessary precaution? Clin Radiol. 69(8): 822–826. DOI: 10.1016/j.crad.2014.03.016
- 30Eijkemans, MJ, van der Wal, W, Reijnders, JJ, et al. Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands. Am J Kidney Dis. 2015; 66(4): 638–645. DOI: 10.1053/j.ajkd.2015.05.016
- 31Urciuoli, P, D’Orazi, V, Livadoti, G, et al. Treatment of renal angiomyolipoma: surgery versus angioembolization. G Chir. 2013; 34(11–12): 326–331.
- 32Seyam, RM, Alkhudair, WK, Kattan, SA, Alotaibi, MF, Alzahrani, HM and Altaweel, WM. The Risks of Renal Angiomyolipoma: Reviewing the evidence. J Kidney Cancer VHL. 2017; 4(4): 13–25. DOI: 10.15586/jkcvhl.2017.97
- 33Prevoo, W, van den Bosch, MAAJ and Horenblas, S. Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology. 2017; 72(1): 188–191. DOI: 10.1016/j.urology.2008.02.059
- 34Makki, A, Graumann, O, Søren, S, et al. J Endourol. 2017; 31(11): 1117–1122. DOI: 10.1089/end.2017.0376
- 35Bissler, JJ and Kingswood, JC. Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: A systematic review. Ther Adv Urol. 2016; 8(4): 279–290. DOI: 10.1177/1756287216641353
- 36Coombs, EJ. Role of mTOR inhibition in the treatment of patients with renal angiomyolipomas. J Am Assoc Nurse Pract. 2013; 25(11): 588–596. DOI: 10.1002/2327-6924.12081